ASSESSMENT OF COSTS ASSOCIATED WITH ADVERSE EVENTS IN PATIENTS WITH CANCER

OBJECTIVES: This study assessed the incremental costs associated with adverse events (AEs) in a range of malignancies. METHODS: Using Truven Health Analytics MarketScan® databases (2000:Q1-2015:Q3), patient-level treatment episodes for breast, gastrointestinal, genitourinary, lung, hematologic, and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-05, Vol.20 (5), p.A98
Hauptverfasser:	CloutierM, M, Yim, YM, Wong, W, Gauthier-Loiselle, M, Gagnon-Sanschagrin, P, Kim, A, Guerin, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Breast cancer Cancer Central nervous system Cough Cough reflex Critical incidents Demography Fistulae Health care expenditures Health insurance Hemorrhage Hypertension Lung cancer Medical diagnosis Mental disorders Nervous system Pain Pancreatitis Patients Prescribing Regression analysis Sepsis Septicemia Side effects Skin cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!